How is Latent-X2 different from Latent-X1?

Latent-X1 focused on macrocyclic peptides and protein mini-binders with strong binding affinities. Latent-X2 advances to antibodies (VHH, scFv) with drug-like developability and demonstrated low ex vivo immunogenicity in initial studies.These profiles emerge without post-generation iteration.